AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Revenue

AXIM Biotechnologies had revenue of $85.35K in the twelve months ending March 31, 2024, with 424.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $52.98K with 616.22% year-over-year growth. In the year 2023, AXIM Biotechnologies had annual revenue of $39.52K with 345.27% growth.

• Revenue (ttm): $85.35K
• Revenue Growth: +424.51%
• P/S Ratio: 47.81
• Revenue / Employee: $14,225
• Employees: 6
• Market Cap: 4.08M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	39.52K	30.64K	345.27%
Dec 31, 2022	8.88K	-51.59K	-85.32%
Dec 31, 2021	60.46K	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	799.48K	603.87K	308.70%
Dec 31, 2018	195.61K	148.04K	311.19%
Dec 31, 2017	47.57K	514.00	1.09%
Dec 31, 2016	47.06K	-2.08K	-4.23%
Dec 31, 2015	49.14K	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	21.67K	-21.67K	-50.00%
Dec 31, 2012	43.33K	33.33K	333.33%
Dec 31, 2011	10.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.